Ovid Therapeutics adds to epilepsy drug pipeline with new AstraZeneca alliance
Ovid Therapeutics is acquiring global rights to AstraZeneca molecules that address a novel target to treat epilepsy. The AstraZeneca deal comes 10 months after Takeda […]